Evidence map›Paper›PMID 35852345›Full record

ArticleMicrobiology spectrum2022

Platelets Inhibit Methicillin-Resistant Staphylococcus aureus by Inducing Hydroxyl Radical-Mediated Apoptosis-Like Cell Death.

Erxiong Liu, Yutong Chen, Jinmei Xu, Shunli Gu, Ning An, Jiajia Xin, Wenting Wang, Zhixin Liu, Qunxing An, Jing Yi and 1 more

Open access · goldAbstract read
In one paragraph

Article in Microbiology spectrum, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Flavonoid-RichMicroorganisms · 2026
    Article
  2. Beyond hemostasis, the immunomodulatory nature of platelets.Research and practice in thrombosis and haemostasis · 2025
    Review
  3. Article
  4. Supernatant of platelet-Microbiology spectrum · 2024
    Article
  5. Review
  6. Article
  7. Celastrol Combats Methicillin-Resistant Staphylococcus aureus by Targeting ΔAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2023
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Erxiong Liu *Department of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Yutong Chen *Department of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Jinmei Xu *Department of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Shunli GuDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Ning AnDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Jiajia XinDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Wenting WangDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Zhixin LiuDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Qunxing AnDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Jing YiDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.
Wen YinDepartment of Transfusion Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shanxi, China.ORCID 0000-0002-7467-2286
Xijing Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most common drug-resistant bacteria and poses a significant threat to human health. Due to the emergence of multidrug resistance, limited drugs are available for the treatment of MRSA infections. In recent years, platelets have been reported to play important roles in inflammation and immune responses, in addition to their functions in blood hemostasis and clotting. We and other researchers have previously reported that platelets can inhibit Staphylococcus aureus growth. However, it remained unclear whether platelets have the same antibacterial effect on drug-resistant strains. In this study, we hypothesized that platelets may also inhibit the growth of MRSA; the results confirmed that platelets significantly inhibited the growth of MRSA

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsAnimalsAnti-Bacterial AgentsApoptosisBlood PlateletsCell DeathHumansHydroxyl RadicalMiceMicrobial Sensitivity TestsAnti-Bacterial AgentsHydroxyl Radicalapoptosis-like deathhydroxyl radicalMRSAplatelets

Identifiers

PMID35852345
PMCPMC9431477
OpenAlexW4286219878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.